Aperio Group’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $10M | Buy |
137,474
+6,527
| +5% | +$461K | 0.03% | 557 |
|
|
2020
Q3 | $8.71M | Buy |
130,947
+8,474
| +7% | +$536K | 0.03% | 520 |
|
|
2020
Q2 | $6.98M | Buy |
122,473
+20,423
| +20% | +$1M | 0.03% | 594 |
|
|
2020
Q1 | $3.58M | Buy |
102,050
+15,637
| +18% | +$745K | 0.02% | 780 |
|
|
2019
Q4 | $4.51M | Buy |
86,413
+3,123
| +4% | +$155K | 0.02% | 775 |
|
|
2019
Q3 | $4.21M | Sell |
83,290
-546
| -0.7% | -$26.9K | 0.02% | 760 |
|
|
2019
Q2 | $4.03M | Sell |
83,836
-2,620
| -3% | -$121K | 0.02% | 793 |
|
|
2019
Q1 | $4.18M | Buy |
86,456
+3,800
| +5% | +$171K | 0.02% | 750 |
|
|
2018
Q4 | $3.4M | Sell |
82,656
-4,780
| -5% | -$196K | 0.02% | 784 |
|
|
2018
Q3 | $3.58M | Buy |
87,436
+6,493
| +8% | +$262K | 0.02% | 799 |
|
|
2018
Q2 | $3.22M | Sell |
80,943
-22,911
| -22% | -$881K | 0.02% | 819 |
|
|
2018
Q1 | $3.88M | Buy |
103,854
+29,612
| +40% | +$1.2M | 0.02% | 744 |
|
|
2017
Q4 | $3.17M | Sell |
74,242
-1,743
| -2% | -$69.5K | 0.02% | 811 |
|
|
2017
Q3 | $2.79M | Sell |
75,985
-6,464
| -8% | -$261K | 0.02% | 809 |
|
|
2017
Q2 | $3.74M | Buy |
82,449
+3,914
| +5% | +$173K | 0.02% | 686 |
|
|
2017
Q1 | $3.34M | Sell |
78,535
-4,511
| -5% | -$184K | 0.02% | 689 |
|
|
2016
Q4 | $3.33M | Buy |
83,046
+28,319
| +52% | +$1.09M | 0.03% | 641 |
|
|
2016
Q3 | $2.13M | Buy |
54,727
+6,245
| +13% | +$236K | 0.02% | 812 |
|
|
2016
Q2 | $1.68M | Sell |
48,482
-1,288
| -3% | -$44.6K | 0.01% | 878 |
|
|
2016
Q1 | $1.72M | Sell |
49,770
-451
| -0.9% | -$15.7K | 0.01% | 839 |
|
|
2015
Q4 | $1.94M | Buy |
50,221
+4,716
| +10% | +$183K | 0.02% | 767 |
|
|
2015
Q3 | $1.78M | Buy |
45,505
+6,816
| +18% | +$270K | 0.02% | 767 |
|
|
2015
Q2 | $1.47M | Buy |
38,689
+5,630
| +17% | +$197K | 0.02% | 829 |
|
|
2015
Q1 | $1.09M | Buy |
33,059
+3,062
| +10% | +$94K | 0.01% | 904 |
|
|
2014
Q4 | $802K | Sell |
29,997
-2,832
| -9% | -$73.1K | 0.01% | 990 |
|
|
2014
Q3 | $799K | Buy |
32,829
+613
| +2% | +$15.5K | 0.01% | 937 |
|
|
2014
Q2 | $817K | Buy |
32,216
+6,992
| +28% | +$163K | 0.01% | 924 |
|
|
2014
Q1 | $542K | Buy |
+25,224
| New | +$544K | 0.01% | 1293 |
|
|
2013
Q4 | – | Sell |
-21,735
| Closed | -$479K | – | 1223 |
|
|
2013
Q3 | $449K | Buy |
21,735
+1,883
| +9% | +$40.1K | 0.01% | 1179 |
|
|
2013
Q2 | $383K | Buy |
+19,852
| New | +$415K | 0.01% | 1153 |
|
Other funds holding HOLX
Aperio Group's HOLX Position: Q4 2020 in Review
Aperio Group increased its Hologic (HOLX) stake by 5% in Q4 2020, buying an estimated $461K and bringing the position to 137,474 shares worth $10M. The position accounts for 0.03% of the portfolio, ranked #557.
Aperio Group first reported a position in HOLX in Q2 2013 and has held it in 30 quarters since. 628 funds tracked by Wall St. Rank hold HOLX as of Q4 2020.
- Aperio Group held 137,474 shares of Hologic worth $10M as of Q4 2020.
- Aperio Group bought 6,527 Hologic shares in Q4 2020, an estimated $461K.
- Hologic made up 0.03% of Aperio Group's portfolio in Q4 2020, its #557 holding.
- Aperio Group first reported a position in Hologic in Q2 2013 and has held it in 30 quarters since.
- 628 funds tracked by Wall St. Rank held Hologic as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.